Annual CFI
$158.35 M
+$99.93 M+171.04%
31 December 2023
Summary:
C4 Therapeutics annual cash flow from investing activities is currently $158.35 million, with the most recent change of +$99.93 million (+171.04%) on 31 December 2023. During the last 3 years, it has risen by +$348.85 million (+183.12%). CCCC annual CFI is now at all-time high.CCCC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$162.00 K
+$11.87 M+101.38%
30 September 2024
Summary:
C4 Therapeutics quarterly cash flow from investing activities is currently $162.00 thousand, with the most recent change of +$11.87 million (+101.38%) on 30 September 2024. Over the past year, it has dropped by -$57.56 million (-99.72%). CCCC quarterly CFI is now -99.72% below its all-time high of $57.73 million, reached on 30 September 2023.CCCC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$32.99 M
-$57.56 M-234.30%
30 September 2024
Summary:
C4 Therapeutics TTM cash flow from investing activities is currently -$32.99 million, with the most recent change of -$57.56 million (-234.30%) on 30 September 2024. Over the past year, it has dropped by -$168.68 million (-124.32%). CCCC TTM CFI is now -120.84% below its all-time high of $158.35 million, reached on 31 December 2023.CCCC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.0% | -99.7% | -124.3% |
| 3 y3 years | +183.1% | +100.2% | +82.1% |
| 5 y5 years | +328.9% | - | - |
CCCC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +183.1% | -99.7% | +100.2% | -120.8% | +82.6% |
| 5 y | 5 years | at high | +183.1% | -99.7% | +100.2% | -120.8% | +86.9% |
| alltime | all time | at high | +183.1% | -99.7% | +100.2% | -120.8% | +86.9% |
C4 Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $162.00 K(-101.4%) | -$32.99 M(-234.3%) |
| June 2024 | - | -$11.71 M(-78.1%) | $24.57 M(-52.2%) |
| Mar 2024 | - | -$53.40 M(-267.1%) | $51.42 M(-67.5%) |
| Dec 2023 | $158.35 M(+171.0%) | $31.95 M(-44.7%) | $158.35 M(+16.7%) |
| Sept 2023 | - | $57.73 M(+281.1%) | $135.69 M(+38.6%) |
| June 2023 | - | $15.15 M(-71.7%) | $97.88 M(-15.6%) |
| Mar 2023 | - | $53.53 M(+476.6%) | $115.96 M(+98.5%) |
| Dec 2022 | $58.42 M | $9.28 M(-53.4%) | $58.42 M(-668.6%) |
| Sept 2022 | - | $19.91 M(-40.1%) | -$10.28 M(-92.1%) |
| June 2022 | - | $33.23 M(-929.9%) | -$130.82 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$4.00 M(-93.3%) | -$131.61 M(-30.5%) |
| Dec 2021 | -$189.34 M(-0.6%) | -$59.41 M(-41.0%) | -$189.34 M(+2.8%) |
| Sept 2021 | - | -$100.63 M(-410.3%) | -$184.09 M(+59.0%) |
| June 2021 | - | $32.43 M(-152.5%) | -$115.78 M(-54.1%) |
| Mar 2021 | - | -$61.73 M(+14.0%) | -$252.05 M(+32.3%) |
| Dec 2020 | -$190.50 M(>+9900.0%) | -$54.17 M(+67.6%) | -$190.50 M(+39.7%) |
| Sept 2020 | - | -$32.32 M(-68.9%) | -$136.34 M(+31.1%) |
| June 2020 | - | -$103.83 M(>+9900.0%) | -$104.02 M(>+9900.0%) |
| Mar 2020 | - | -$184.00 K | -$184.00 K |
| Dec 2019 | -$1.62 M(-104.4%) | - | - |
| Dec 2018 | $36.92 M | - | - |
FAQ
- What is C4 Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for C4 Therapeutics?
- What is C4 Therapeutics annual CFI year-on-year change?
- What is C4 Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for C4 Therapeutics?
- What is C4 Therapeutics quarterly CFI year-on-year change?
- What is C4 Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for C4 Therapeutics?
- What is C4 Therapeutics TTM CFI year-on-year change?
What is C4 Therapeutics annual cash flow from investing activities?
The current annual CFI of CCCC is $158.35 M
What is the all time high annual CFI for C4 Therapeutics?
C4 Therapeutics all-time high annual cash flow from investing activities is $158.35 M
What is C4 Therapeutics annual CFI year-on-year change?
Over the past year, CCCC annual cash flow from investing activities has changed by +$99.93 M (+171.04%)
What is C4 Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CCCC is $162.00 K
What is the all time high quarterly CFI for C4 Therapeutics?
C4 Therapeutics all-time high quarterly cash flow from investing activities is $57.73 M
What is C4 Therapeutics quarterly CFI year-on-year change?
Over the past year, CCCC quarterly cash flow from investing activities has changed by -$57.56 M (-99.72%)
What is C4 Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CCCC is -$32.99 M
What is the all time high TTM CFI for C4 Therapeutics?
C4 Therapeutics all-time high TTM cash flow from investing activities is $158.35 M
What is C4 Therapeutics TTM CFI year-on-year change?
Over the past year, CCCC TTM cash flow from investing activities has changed by -$168.68 M (-124.32%)